Andrew H. Beck, M.D., Ph.D.

Andrew BeckAssistant Professor
Department of Pathology
Harvard Medical School

Molecular Epidemiology Research Laboratory
Beth Israel Deaconess Medical Center

Dr. Andrew Beck is an Assistant Professor in the Department of Pathology at Harvard Medical School and Director of the Molecular Epidemiology Research Laboratory at Beth Israel Deaconess Medical Center. Dr. Beck completed a Masters of Medical Science in Biostatistics and an M.D. from Brown Medical School. He completed his residency in Anatomic Pathology and clinical fellowship in Molecular Genetic Pathology from Stanford in 2010. He then joined the program in Advanced Residency Training at Stanford and completed a Ph.D. in Biomedical Informatics from Stanford University.

The goal of the Beck laboratory is to develop, apply, and integrate methods in molecular pathology, biomedical informatics, and computational image analysis for translational cancer research, leading to improved diagnostics and therapeutics for patients. A major focus of the lab is the development of the Computational Pathology (C-Path) platform for the quantitative analysis of cancer histopathology and in situ molecular data, incorporating features of both malignant epithelial cells and stromal cells in the tumor microenvironment. The laboratory’s ultimate goal is to create new computational and molecular tools to enable cancer physicians to provide accurate and predictive diagnostics, enabling more individualized and effective therapies and leading to improved patient outcomes.